
Dipentyl succinate | CAS:645-69-2
Dipentyl succinate
- 名称:丁二酸二戊酯 | Dipentyl succinate
- CAS号:645-69-2
- 别名:Butanedioic acid dipentyl ester
- 分子式:C14H26O4
- 分子量:258.36
- EINESC号:211-452-5
产品描述
物理化学性质
没有数据 | 没有数据 |
---|
安全数据
没有数据 | 没有数据 |
---|
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Phenylbutazone pharmacokinetics and bioavailability in the dromedary camel (Camelus dromedarius).A Kadir et al.Journal of veterinary pharmacology and therapeutics, 20(1), 54-60 (1997-02-01)
Pharmacokinetic and pharmacodynamic studies on phenylbutazone and oxyphenbutazone in goats.Z Cheng et al.The Veterinary record, 140(2), 40-43 (1997-01-11)
Pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in miniature donkeys.N S Matthews et al.American journal of veterinary research, 62(5), 673-675 (2001-05-09)
Antirheumatic effect of pirfenidone in a double blind clinical pilot trial in humans.E Pesce et al.Research communications in molecular pathology and pharmacology, 115-116, 39-48 (2007-06-15)
Screening, quantification, and confirmation of phenylbutazone and oxyphenbutazone in equine plasma by liquid chromatography-tandem mass spectrometry.Youwen You et al.Journal of analytical toxicology, 33(1), 41-50 (2009-01-24)
Analysis of adulterants in a traditional herbal medicinal product using liquid chromatography-mass spectrometry-mass spectrometry.Aik-Jiang Lau et al.Journal of pharmaceutical and biomedical analysis, 31(2), 401-406 (2003-03-01)
Interactions of oxyphenbutazone with different cyclodextrins in aqueous medium and in the solid state.M D Veiga et al.Journal of pharmaceutical and biomedical analysis, 28(5), 973-982 (2002-06-01)
Disposition and tolerance of suxibuzone in horses.M V Jaraiz et al.Equine veterinary journal, 31(5), 411-416 (1999-10-03)
Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part II.S Chaplin Adverse drug reactions and acute poisoning reviews, 5(3), 181-196 (1986-01-01)
Ulcer of the cecum during oxyphenbutazone (tandearil) therapy.Debenham G P Canadian Medical Association Journal, 94(22), 1182-1182 (1966)
Determination of non-steroidal anti-inflammatory drugs residues in animal muscles by liquid chromatography-tandem mass spectrometry.Piotr Jedziniak et al.Analytica chimica acta, 672(1-2), 85-92 (2010-06-29)
Pretreatment of astrocytes with interferon-alpha/beta impairs interferon-gamma induction of nitric oxide synthase.V C Stewart et al.Journal of neurochemistry, 68(6), 2547-2551 (1997-06-01)
Pharmacokinetics of intravenous and intragastric cimetidine in horses. I. Effects of intravenous cimetidine on pharmacokinetics of intravenous phenylbutazone.R A Sams et al.Journal of veterinary pharmacology and therapeutics, 20(5), 355-361 (1997-11-14)
Pharmacokinetics of phenylbutazone in camels.I A Wasfi et al.American journal of veterinary research, 58(6), 636-640 (1997-06-01)
Pharmacokinetic studies of flunixin meglumine and phenylbutazone in plasma, exudate and transudate in sheep.Z Cheng et al.Journal of veterinary pharmacology and therapeutics, 21(4), 315-321 (1998-09-10)
Evaluation of dosage forms. VI. Studies of commercial oxyphenbutazone tablet dosage forms.B Razdan et al.Drug development and industrial pharmacy, 25(9), 1051-1056 (1999-10-13)
Phospholipase A2 as a target protein for nonsteroidal anti-inflammatory drugs (NSAIDS): crystal structure of the complex formed between phospholipase A2 and oxyphenbutazone at 1.6 A resolution.Nagendra Singh et al.Biochemistry, 43(46), 14577-14583 (2004-11-17)
Direct injection HPLC method for the determination of phenylbutazone and oxyphenylbutazone in serum using a semipermeable surface column.A Haque et al.Journal of pharmaceutical and biomedical analysis, 16(2), 287-293 (1997-12-31)
Mutagenicity assay in Salmonella and in vivo sister chromatid exchange in bone marrow cells of mice for four pyrazolone derivatives.A K Giri et al.Mutation research, 420(1-3), 15-25 (1998-12-05)
Structural and ligand-binding properties of serum albumin species interacting with a biomembrane interface.Takamitsu Kosa et al.Journal of pharmaceutical sciences, 96(11), 3117-3124 (2007-11-06)
Newer pharmacological data on oxyphenbutazone.G Wilhelmi Japanese journal of pharmacology, 15(2), 187-198 (1965-06-01)
Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part I.S Chaplin Adverse drug reactions and acute poisoning reviews, 5(2), 97-136 (1986-01-01)
Systemic treatment of sarcoidosis.Philip I Murray et al.Ocular immunology and inflammation, 19(2), 145-150 (2011-03-25)
Determination of binding conformations of drugs to human serum albumin by transferred nuclear overhauser effect measurements and conformational analyses using high-temperature molecular dynamics calculations.Y Matsushita et al.Journal of pharmaceutical sciences, 87(3), 379-386 (1998-04-02)
Simultaneous determination of hydrocortisone, dexamethasone, indomethacin, phenylbutazone and oxyphenbutazone in equine serum by high-performance liquid chromatography.E Grippa et al.Journal of chromatography. B, Biomedical sciences and applications, 738(1), 17-25 (2000-04-25)
4-Hydroxy-oxyphenbutazone is a potent inhibitor of cytokine production.Anja Ten Brinke et al.European cytokine network, 16(2), 144-151 (2005-06-09)
Interaction of human serum albumin with the electrophilic metabolite 1-O-gemfibrozil-beta-D-glucuronide.B C Sallustio et al.Drug metabolism and disposition: the biological fate of chemicals, 25(1), 55-60 (1997-01-01)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!